Table 2:
Anti-Hypertensives-Induced Laboratory Changes in Diabetic Patients with Cardiovascular Complications
| DRUGS | ASSOCIATED LABORATORY CHANGES |
|---|---|
| ACE Inhibitors | Azotaemia [11,12], Hyperbilirubinemia [41], elevates liver enzymes [41], reduces proteinuria [43] |
| Diuretics | |
| a. Thiazide | Dyslipidaemia [20-22], hypokalemia [14], hyponatremia [14], hypomagnesemia [23], hypercalcemia[18],hyperglyceamia[24,25],hyperuricemia[27] |
| b. Loop | Hyponatremia[13],hypocalcemia[26],hypomagnesemia[23],hyperuricemia[27] |
| c. Potassium sparing | Hyperkalemia[27], metabolic acidosis[27] |
| Beta blockers | Dyslipidemia[28,29],hyperglycemia[34] |
| Centrally acting alpha 2 Adrenergic Agonist-methyldopa | Hyperbilirubinemia[37],elevates liver enzymes[37], hypernatremia[37], hyperchloremia[37] hypermagnesemia[37], hyperkalemia[37] |